Cite
The catechol-O-methyltransferase Val158Met polymorphism modulates fronto-cortical dopamine turnover in early Parkinson’s disease: a PET study.
MLA
Wu, Kit, et al. “The Catechol-O-Methyltransferase Val158Met Polymorphism Modulates Fronto-Cortical Dopamine Turnover in Early Parkinson’s Disease: A PET Study.” Brain: A Journal of Neurology, vol. 135, no. 8, Aug. 2012, pp. 2449–57. EBSCOhost, https://doi.org/10.1093/brain/aws157.
APA
Wu, K., O, K. D., Politis, M., O, K. G. C., Robbins, T. W., Bose, S. K., Brooks, D. J., Piccini, P., & Barker, R. A. (2012). The catechol-O-methyltransferase Val158Met polymorphism modulates fronto-cortical dopamine turnover in early Parkinson’s disease: a PET study. Brain: A Journal of Neurology, 135(8), 2449–2457. https://doi.org/10.1093/brain/aws157
Chicago
Wu, Kit, Keeffe, Deirdre O, Marios Politis, Keeffe, Grainne C. O, Trevor W. Robbins, Subrata K. Bose, David J. Brooks, Paola Piccini, and Roger A. Barker. 2012. “The Catechol-O-Methyltransferase Val158Met Polymorphism Modulates Fronto-Cortical Dopamine Turnover in Early Parkinson’s Disease: A PET Study.” Brain: A Journal of Neurology 135 (8): 2449–57. doi:10.1093/brain/aws157.